189 filings
Page 4 of 10
6-K
6h6t02ii5odo0o0r49
25 Aug 20
Company announcement – No. 44 / 2020
7:58am
6-K
ow7c6
14 Aug 20
Interim report for H1 2020
6:17am
6-K
z7gzmos9bz
6 Jul 20
Current report (foreign)
12:43pm
6-K
cu3hlpct
30 Jun 20
Current report (foreign)
12:10pm
6-K
hhkq04
25 Jun 20
Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1/glucagon dual agonist in obesity/diabetes
11:22am
6-K
2cy 1wsr8xcs
25 Jun 20
Current report (foreign)
11:18am
6-K
tz87c8
22 Jun 20
Company announcement – No. 36 / 2020
4:07pm
6-K
u59jd1xumak
18 Jun 20
Company announcement – No. 34 / 2020
1:27pm
6-K
d2s5a3t0
16 Jun 20
Company announcement – No. 32 / 2020
6:01am
6-K
t778zwki51dm01xmmu
15 Jun 20
Company announcement – No. 33 / 2020
5:06pm
6-K
ksk8dia8i8y
29 May 20
Current report (foreign)
4:09pm
6-K
3o3vr8d b65hu247dm
29 May 20
Current report (foreign)
4:08pm
6-K
6z35 8u9ux37xomh
27 May 20
Company announcement – No. 29 / 2020
3:53pm
6-K
lryhsqw79cg
26 May 20
Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia
3:21pm
6-K
snj jf0v0xy9kqukhq6b
22 May 20
Company announcement – No. 27 / 2020
4:55pm
6-K
cpxemvd56ob7s6lhy86
15 May 20
Interim report for Q1 2020
5:04pm
6-K
vkwh94lbi70f
1 May 20
Company announcement – No. 24 / 2020
6:36am
6-K
82znjlmjy
22 Apr 20
Company announcement – No. 22 / 2020
12:00am
6-K
8z2ta
9 Apr 20
Company announcement – No. 18 / 2020
12:00am
6-K
qoht49dutp1403i
7 Apr 20
Zealand Pharma’s Annual General Meeting 2020
6:22am